Thankful for another day of finding beauty in this journey called life.
I live a well rounded lifestyle by taking care of myself health wise.
Here are my 3 shopping categories that I follow when I go to the market (grocery store).
Article By Aura Carter
ALT (Advanced Liquid Technology) has entered into an agreement with UK-based medical cannabis provider Grow Group Plc to launch and market its liquid medical cannabis products across Europe.
ALT’s proprietary, fast-acting medical cannabis product is neutral in flavor, zero-calorie, sugar-free, vegan, keto, and paleo-friendly and are designed to allow for more effective delivery in comparison to other products such as tinctures and sprays.
Medical cannabis patients will reportedly benefit from a more rapid onset time of between 5-15 minutes and more efficient absorption. ALT’s water-compatible products are made using kinetically stabilized nanoemulsions which allow cannabinoids to be effectively absorbed by the body.
ALT offers precise dosing of cannabinoids, allowing patients and clinicians to tailor treatment based on individual needs and requirements for a range of health conditions.
“We are [honored] to partner with GROW in bringing ALT’s completely differentiated brand and liquid medical cannabis technologies to the European medical markets,” said ALT CEO Robert Davis.
“After successfully launching ALT into California in December 2020, we are excited to expand internationally, our first step towards becoming a global brand. ALT’s mission is to Enhance Human Potential and we will do so, one patient at a time, through the power of our liquid cannabis platform.”
Through its new partnership with Grow Group Plc, ALT aims to have a range of EU GMP-certified medical cannabis products available to European patients through prescription by early 2022.
Grow GroupPlc CEO, Ben Langley stated: “Grow’s mission is to bring medical cannabis products to all patients who need them.
“We strive to constantly improve and innovate on our product offering. With our leading position and unique experience we are very confident that with ALT’s new mode of administration, using liquid medical cannabis, we are going to make another leap forward in providing patients with the best products and solutions for their symptom management.”
Grow Group Plc recently announced the launch of a crowdfunding campaign with Seedrs, seeking £3.2 million ($3,740,080.00 USD) of investment from “socially conscious shareholders.”
Article By Emily Ledger – Canex.com UK
Get new content delivered directly to your inbox.
CBD is all the rage these days, and it’s no wonder. Now you can experience for yourself this incredible, natural ingredient that has clients raving. Prosper Wellness uses full spectrum CBD for maximum benefits.
150mg of High Quality CBD in Every Jar
Featuring Full Spectrum Cannabidiol (CBD), Arnica, Castor Oil, Peppermint Oil, Aloe, Green Tea Extract, Willow Bark Extract, and Menthol
Get new content delivered directly to your inbox.
Legal marijuana sales in multiple states reached record highs in mid-2020 as coronavirus spread across the nation, according a new study. To date, sales in the four states examined in the analysis—Alaska, Colorado, Oregon and Washington—”have increased more during the COVID-19 pandemic than in the previous two years.”
The study, authored by a group of health researchers, gathered pre-tax cannabis sales data from state regulatory agencies and compared those numbers over time. It found that even amid stay-at-home orders that dealt hard hits to other economic sectors, cannabis sales picked up speed.
“Findings show a general increase in cannabis sales following stay-at-home orders issued in AK, CO, OR, and WA in late March 2020,” the report, published last week in the International Journal of Drug Policy, says. “In all four states, those increases were greater than the percent increases observed in the preceding two years.”
Authors include researchers at the U.S. Centers for Disease Control and Prevention (CDC), the University of Washington’s Drug and Alcohol Institute and health and regulatory agencies in several states. While official data releases and news articles documented the spike in marijuana sales as it occurred, the new report calls itself “the first study in the academic literature to document changes in U.S. cannabis sales data during the COVID-19 pandemic.”
While the authors didn’t attempt to determine the causes behind the increased sales, they speculated the boost might be related to a number of different factors: increased cannabis use among individuals coping with stress, stay-at-home orders pushing consumers from the illicit market to licensed stores, possible price increases due to rising demand and/or purchasing of more expensive cannabis products, such as concentrates and oils.
Continue Reading Article By Marijuana Moment
Get new content delivered directly to your inbox.
Yahoo! Finance | This research report provides an in-depth analysis of the CBD-infused products market across five major geographies and emphasizes on the current market trends, market size, market shares, recent developments, and forecast till 2028. The CBD-infused Products Market is expected to reach $216.8 billion by 2028, at a CAGR of 45.6% during the forecast period, 2021-2028.
The growth of this market is mainly attributed to the rising demand and increasing legalization of cannabis, growing application of cannabis in cancer, and health benefits offered by cannabis-infused products are also a few of the key factors driving the growth of the CBD-infused products market.
The study offers a comprehensive analysis of the CBD-infused products market with respect to the source (hemp and marijuana), type (CBD-edibles {confectionery products, bakery products, beverages [non-alcoholic beverages and alcoholic beverages], coffee & tea products, and other products}, CBD-oil and extracts, CBD-personal care products {skincare products, haircare products, deodorants and perfumes, and other personal care products}, CBD-smoke & vape products, CBD-supplements, CBD-pet products, and other CBD-products), distribution channel (offline store {dispensary, pharmacies, natural health foods store, and other stores} and online store), and geography. The study also evaluates industry competitors and analyzes the market at the country level.
Based on source, the CBD-infused products market is mainly segmented into hemp and marijuana. The hemp segment is estimated to account for the largest share of the CBD-infused products market in 2021. The large share of this segment is mainly attributed to its lower THC concentrations, which decrease or eliminate its psychoactive effects and increase hemp-derived products for various medical applications. Also, its anti-inflammatory, anti-aging, antioxidant properties, and high effectiveness of CBD extracted from hemp is a key factor for the large share of this segment. However, it is also expected to witness significant growth, as some governments regulate the concentration of THC and permit only hemp with an especially low THC content.
Based on type, the CBD-infused products market is segmented into CBD-edibles, CBD-oil and extracts, CBD-personal care products, CBD-smoke & vape products, CBD-supplements, CBD-pet products, and other CBD-products. The CBD-edibles segment is estimated to account for the largest share of the CBD-infused products market in 2021. The large share of this segment is mainly attributed to the growing popularity of recreational cannabis, increasing demand for food infused by cannabis such as THC and CBD, rising adoption of CBD in different verticals such as confectionery, bakery, etc., and cannabis consumer are looking for alternatives to smoking cannabis. Also, the increasing use of CBD-edibles to treat psychiatric disorders, neurological disorders, and cancer, along with pain control, is expected to drive the demand for CBD-edibles. However, it is also expected to grow at the highest CAGR during the forecast period.
Based on distribution channel, the CBD-infused products market is segmented into offline and online stores. The offline stores segment is estimated to account for the largest share of the CBD-infused products market in 2021. The large share of this segment is mainly attributed to the perception of purchasing authentic and good quality products. However, the online store segment is expected to grow at the highest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to the ease of convenience and rapid penetration of CBD-infused products on E-commerce platforms. Also, the availability of CBD-infused drinks on leading online platforms is playing a crucial role in the CBD-infused products market.
Geographically, the market is segmented into five major regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The North American region is estimated to account for the largest share of the CBD-infused products market in 2021. The large share of this region is primarily attributed to the ease of accessibility, technological advancements in CBD-infused products production and processing, a large base of CBD consumers, changing perceptions towards CBD consumption for both medical and recreational purposes, growing awareness regarding various medical benefits of CBD among users, and increasing investments from leading players.
The key players operating in the CBD-infused products market are Canopy Growth Corporation (Canada), Aphria, Inc. (Canada), Aurora Cannabis Inc. (Canada), Docklight Brands, Inc. (U.S.), Maricann Inc. (Canada), Tilray, Inc. (Canada), GW Pharmaceuticals plc (U.K.), VIVO Cannabis Inc. (Canada), Cresco Labs, Inc. (U.S.), Tauriga Sciences, Inc. (U.S.), MariMed Inc. (U.S.), CV Sciences, Inc. (U.S.), Puration, Inc. (U.S.), Kona Gold Solutions Inc. (U.S.), Bhang Inc. (U.S.), DT Brands & Co (N.I.) Ltd. (U.S.), Forest Coffee Trading Co. (U.S.), G&Juice (U.S.), Honeydrop Beverages Inc. (U.S.), and Elixinol Global Limited (Australia).
Story Continues
EarthyRealist.com 